• Info
  • Insider Ownership

Insider Trading & Ownership of John W. Smither

Location
Westlake Village, CA
Summary
The estimated net worth of John W. Smither is at least $1,170,696 dollars as of 18 Mar 2026. John W. Smither is the Chief Financial Officer of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $540.9K. John W. Smither is the Director of NewAmsterdam Pharma Co N.V. and owns shares of NewAmsterdam Pharma Co N.V. (NAMS) stock worth about $363.6K. John W. Smither is the Director of GENELUX Corp and owns shares of GENELUX Corp (GNLX) stock worth about $266.2K.
Signature
John W. Smither
All Insider Reports
All Insider Reports

Notify me when John W. Smither files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of John W. Smither

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARQT Arcutis Biotherapeutics, Inc. Chief Financial Officer $540,882 13 Feb 2024
NAMS, NAMSW NewAmsterdam Pharma Co N.V. Director $363,586 07 Jan 2026
GNLX GENELUX Corp Director $266,228 27 Aug 2025
AMTI Applied Molecular Transport Inc. Director 27 Dec 2023
EFTR eFFECTOR Therapeutics, Inc. Director 22 Jun 2023
MBX MBX Biosciences, Inc. Chief Financial Officer 16 Mar 2026

Insider Transactions Reported by John W. Smither:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.